The IMPACT of the COVID-19 Pandemic on Prescription Drug Use in Patients with Psoriasis Vulgaris in Germany
Abstract Introduction Real-world evidence (RWE) data is increasingly important to generate rapid insights to effectively manage patient populations. Disruptions like the coronavirus disease 2019 (COVID-19) pandemic may negatively impact the choice of medications used for managing chronic diseases su...
Saved in:
Main Authors: | Maria Kahn (Author), Steffeni Papukchieva (Author), Elizabeth Jacyshyn-Owen (Author), Stefan Grimm (Author), Markus Eberl (Author), Sebastian Schneeweiss (Author), Marina Otten (Author), Matthias Augustin (Author), Benjamin Friedrich (Author) |
---|---|
Format: | Book |
Published: |
Adis, Springer Healthcare,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development, Feasibility, and Acceptability of the Electronic Patient Benefit Index for Psoriasis in Clinical Practice: Mixed Methods Study
by: Marina Otten, et al.
Published: (2024) -
Quality of Life in Psoriasis Vulgaris: Use of the ItchyQoL Questionnaire in a Secukinumab Phase III Trial in Patients with Psoriasis Vulgaris
by: Sonja Ständer, et al.
Published: (2019) -
Sociodemographic and Environmental Determinants of Regional Prevalence of Psoriasis in Germany: A Spatiotemporal Study of Ambulatory Claims Data
by: Valerie Andrees, et al.
Published: (2024) -
Verrucous Psoriasis - Atypical Variant of Psoriasis Vulgaris
by: Akshaya R.C, et al.
Published: (2022) -
Pseudoainhum associated with Psoriasis vulgaris
by: Mrinal Gupta, et al.
Published: (2015)